Adverse reactions to cromolyn sodium: patient report and review of the literature.
Lester
M R
MR
Pediatric Asthma Center, Children's Hospital, Boston, Massachusetts 02115, USA.
Bratton
D L
DL
D000420:Albuterol / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001507:Beclomethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002974:Clemastine / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014555:Urination Disorders / Q000139:chemically induced*; D014718:Vesico-Ureteral Reflux / Q000139:chemically induced*
D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D002974:Clemastine; D013806:Theophylline; D001507:Beclomethasone; D004205:Cromolyn Sodium; D000420:Albuterol; D011241:Prednisone